Hasil Pencarian  ::  Simpan CSV :: Kembali

"With a special emphasis on the complementary nature of anatomic and functional cardiac data, this book ensures physicians develop the skills they need to interpret cardiac CT images. New chapters address evaluation of the thoracic aorta, congenital heart disease in the adult, triple rule-out CT angiography, and the latest innovations in cardiac CT. "

"Clinical cardiac MRI is a comprehensive textbook intended for everyone involved in magnetic resonance imaging of the heart. It is designed both as a useful guide for newcomers to the field and as an aid for those who routinely perform such studies. Providing theoretical background information, this illustrated volume examines imaging acquisition and potential pitfalls. It presents guidelines on the interpretation of clinical data in a range of cardiac pathology that can be encountered. In this second edition, the aim has been to maintain the same quality while incorporating the newest insights and developments in this rapidly evolving domain of medical imaging. Finally, the selection of 100 real-life cases, added as online material, will further enhance the value of this textbook."

"The rapid advances in CCT technology, the advent of new clinical applications, and the acquisition of data on prognostic value are just some of the reasons for the publication of this new edition of Clinical Applications of Cardiac CT, little more than 3 years after the first edition appeared. The text has been extensively revised and updated to reflect current knowledge and practice, and the structure and layout of the educational content have also been improved. The imaging targets, semeiology, technique, and clinical applications of CCT are all covered in detail, and in addition relevant information is provided on epidemiology, clinical assessment, and the role of other diagnostic modalities. This book will prove an invaluable tool for radiologists and cardiologists alike."

"Therapeutic hypothermia has emerged as a very important treatment option for patients with cardiac arrest as it provides significant protection from developing neurologic injury once the patient has been successfully resuscitated. Studies have demonstrated over 15% absolute risk reduction in death and neurologic injury using this therapy. Although hospitals and medical centers have become familiar with this important intervention it still remains greatly under utilized due to an experience and lack of resources to safely and effectively deploy such a program. The objective of this book is to educate and familiarize both providers and institutions as to how to develop and deploy and provide therapeutic hypothermia to their patients. The current knowledge for this is provided by speakers and national experts and also by literature review. There are several courses being provided on this as well throughout the US. These are good venues for people to come and see and get hands on experience, but there still needs to be a concrete book with references on how to go about getting this program started."

"Pendahuluan: Optimalisasi pelayanan resusitasi dapat dipadupadankan dengan teknologi yang berkembang saat ini, salah satunya adalah aplikasi seluler yang dapat diterapkan dengan mudah dalam sistem pelayanan resusitasi. Cardiac Arrest Resuscitation Mobile Application (CARMA) merupakan alat bantu dalam ACLS yang digunakan untuk membantu para praktisi dalam melakukan tindakan resusitasi. Penggunaan aplikasi dapat dimulai pada pelatihan berbasis simulasi. Metode: Penelitian ini adalah uji klinis acak pada simulasi henti jantung dengan menggunakan manekin fidelitas tinggi. Simulasi dengan durasi dua belas menit dan berupa lima rangkaian ritme. Sejumlah 26 kelompok mahasiswa kedokteran dibagi kedalam dua kelompok, yaitu kelompok menggunakan aplikasi dan standar. Tujuan utama penelitian adalah untuk membandingkan kepatuhan panduan klinis pada kedua kelompok. Penilaian kepatuhan berdasarkan persentase pemenuhan daftar tilik yang sudah tervalidasi dan sudah dilakukan uji realibilitas sebelumnya. Tujuan sekunder untuk menilai kualitas kompresi dada dan waktu pemberian epinefrin. Hasil: Terdapat perbedaan bermakna kepatuhan panduan klinis pada kelompok aplikasi dibandingkan dengan kelompok standar (88,95 ± 6,86 vs 73,98 ± 6,40, p < 0,001). Variabel yang tidak menunjukkan perbedaan bermakna pada penelitian ini antara lain adalah kedalaman kompresi dada dan interval waktu pemberian epinefrin.Simpulan: Penggunaan aplikasi seluler dapat meningkatkan kepatuhan panduan klinis pada simulasi kasus henti jantung.

---

Background: The optimization of resuscitation services can be aligned with current technological advancements, including mobile applications that can be easily implemented in resuscitation services. The Cardiac Arrest Resuscitation Mobile Application (CARMA) is a tool in Advanced Cardiovascular Life Support (ACLS) designed to assist practitioners in performing resuscitation actions. The application's use can commence in simulation-based training.

Methods: This study is a randomized clinical trial on cardiac arrest simulation using a high-fidelity mannequin. The simulation lasted twelve minutes and included five rhythm sequences. Twenty-six groups of medical students were divided into two groups: one using the application and the other following standard procedures. The main objective of the study was to compare compliance with clinical guidelines in both groups. Compliance assessment was based on the percentage of validated checklist items, previously subjected to reliability testing. Secondary objectives included evaluating chest compression quality and epinephrine administration time. Results: There was a significant difference in compliance with clinical guidelines between the application group and the standard group (88.95 ± 6.86 vs. 73.98 ± 6.40, p < 0.001). Variables such as chest compression depth and epinephrine administration interval did not show significant differences in this study. Conclusion: The use of mobile applications can enhance compliance with clinical guidelines in cardiac arrest simulation cases."

"ABSTRAKLatar belakang: Kardioplegia merupakan komponen penting dalam proteksi miokard operasi jantung. Meskipun telah banyak penelitian yang mencoba membuktikan keunggulan kardioplegia darah dibanding kardioplegia kristaloid, namun kesepakatan kardioplegia terbaik untuk operasi jantung bawaan asianotik belum tercapai. Metode: Penelitian eksperimental dengan simple randomization pada 54 populasi pasien VSD, AVSD dan gangguan katup mitral yang dibagi menjadi dua kelompok, yaitu 24 pasien kelompok crystalloid cardioplegia CC sebagai kontrol, dan 30 pasien kelompok blood cardioplegia BC . Dilakukan pemeriksaan selisih kadar laktat darah arteri dan sinus koronarius, serta ekstraksi oksigen koroner segera, menit ke-15 dan menit ke-30 setelah CPB dihentikan. Dilakukan observasi terhadap durasi ventilasi mekanik, penggunaan inotropik, aritmia jantung, lama rawat icu dan lama rawat rumah sakit. Hasil: Selisih kadar laktat darah dan ekstraksi oksigen koroner tidak berbeda bermakna p>0,05 . Pada pasien tutup VSD, penggunaan intoropik lebih sedikit pada kelompok BC. Pasien tanpa inotropik kelompok BC dan CC yaitu 9/25 dan 2/22, 1 jenis inotropik 12/25 dan 13/22, dan lebih dari satu jenis inotropik 4/25 dan 7/22

---

ABSTRACTBackgrounds Cardioplegia is an important myocardial protection in cardiac surgery. Many studies conducted to prove blood cardioplegia rsquo s superiority to crystalloid cardioplegia, but no agreement established for which cardioplegia is the best for acyanotic cardiac surgery. Methods Experimental study with simple randomization in 54 VSD, AVSD, and mitral valve disease patients, 24 crystalloid cardioplegia CC , and 30 blood cardioplegia BC . Lactate levels in arterial blood and coronary sinus, also coronary oxygen extractions were measured immediate, 15 and 30 minutes after CPB deactivated. Postoperative mechanical ventilation durations, inotropic administrations, arrhytmias, ICU and hospital length of stay were observed. Results No significant difference in the difference of lactate levels and coronary oxygen extractions immediate, 15 and 30 minutes after CPB P 0.05 . Less inotropics needed in VSD closure patients in BC group. No inotropic needed in 9 25 BC group to 2 22 in CC group, 1 inotropic needed in 12 25 BC group to 13 22 in CC group, and more than 1 intropic needed in 4 25 BC group to 7 22 in CC group p"